| Literature DB >> 34268184 |
Tin Htet Oo1,2, Sukanya Tianviwat3, Songchai Thitasomakul1.
Abstract
OBJECTIVES: The study aims at reviewing Myanmar's current situation to consider an improved oral health system and at promoting the oral health status of the Myanmar population.Entities:
Keywords: Dental workforce; Myanmar; essential medicine; health financing; leadership and governance; oral health information; oral health service delivery; oral health system
Year: 2021 PMID: 34268184 PMCID: PMC8257009 DOI: 10.4103/jispcd.JISPCD_438_20
Source DB: PubMed Journal: J Int Soc Prev Community Dent ISSN: 2231-0762
Prevalence of dental caries and decayed, missing, filled teeth (DMFT/dmft) by age groups in Myanmar
| Study | Study year | Study area | Age | Number of people | Caries prevalence (%) | dmft/DMFT | Untreated caries (%) |
|---|---|---|---|---|---|---|---|
| Thwin | 2015 | Yangon | 3 | 318 | 78.9 | 5.69 | |
| Thwin | 2012 | Chin State | 20–45 | 50 | 90.8 | 3.08 | |
| Pathfinder survey[ | 2006 | Taungyi, Mandalay, Pathein, Mawlamyine | 5 | 779 | 81.7 | 5.21 | |
| National Oral Health survey[ | Dec 2016–Jan 2017 | 21 townships | 6 | Total—6300 | 5.7 | 84.1 | |
| Chu | 2009 | Rural (Shan State) | 5 | 95 | 25 | 0.9 | |
| Aung | 2009–2010 | Thingyangyun and North Okkala (Yangon) | 21–23 (teacher) 21–23 (factory worker) | 147 | 35.4 | 0.91 | |
| Mon | 2014 | North Okalarpa (Yangon) Tharyarwady (Bago) | 15 (school children) | 217 | 44.7 | 0.98 |
Chart 1Organization chart of departments under the Ministry of Health and Sports (MOHS)
Figure 1Number of dentists and dental nurses working in the public and private sector
Figure 2Number of dentists working in the public sector by 14 states/regions and Nay Pyi Taw Union territory
Local anesthesia and anti-bacterial drugs for dental use Category A = for any doctor, B= Alternative to A, C = for experienced doctors, D, E1 =Trained personnel with expert qualifications (drugs to be used in the specialized center)
| Local anaesthesia | Route of administration | Strength | Category |
|---|---|---|---|
| Lignocaine (hydrochloride) | Dental cartridge | 2% + 1:80,000 adrenaline | A |
| Lignocaine + epinephrine | Dental cartridge | 2% (lidocaine hydrochloride) + 1:80,000 epinephrine 1%, 2% (lidocaine hydrochloride or sulfate) + 1:200,000 epinephrine in vial | A |
| Amoxicillin (trihydrate) (sodium salt) | Tablet/capsule | 250 mg, 500 mg | A |
| Amoxicillin with clavulanic acid (Co-amoxiclav) | Tablet | 375 mg, 625 mg | A |
| Cephalexin | Tablet/capsule | 250 mg, 500 mg | A |
| Ceftriaxone | Injection | 1g, 2g/vial | C, E1 |
| Cloxacillin | Capsule | 250 mg, 500 mg | A |
| Flucloxacillin | Capsule | 250 mg, 500 mg | A |
| Azithromycin | Tablet/capsule | 250 mg, 5000 mg | C |
| Clarithromycin | Solid oral dosage form | 500 mg | D |
| Clindamycin | Capsule | 150 mg, 300 mg | B |
| Lincomycin | Capsule | 250 mg, 500 mg | C |
| Metronidazole | Tablet | 200 mg, 500 mg | A |
| Norfloxacin | Tablet | 400 mg | A |
Figure 3Government expenditure on health care (2014–2022f), USD millions